Maraviroc intensification for suboptimal CD4⁺ T cell response in a perinatally HIV-infected adolescent

AIDS. 2011 Jun 1;25(9):1243-4. doi: 10.1097/QAD.0b013e3283474187.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • CD4-Positive T-Lymphocytes / drug effects*
  • CD4-Positive T-Lymphocytes / immunology
  • Cyclohexanes / administration & dosage*
  • Female
  • HIV Fusion Inhibitors / administration & dosage*
  • HIV Infections / drug therapy*
  • HIV Infections / immunology
  • HIV-1 / drug effects*
  • HIV-1 / immunology
  • Humans
  • Infectious Disease Transmission, Vertical*
  • Male
  • Maraviroc
  • Pregnancy
  • Pregnancy Complications, Infectious
  • Triazoles / administration & dosage*

Substances

  • Cyclohexanes
  • HIV Fusion Inhibitors
  • Triazoles
  • Maraviroc